References
- Aderotoye-Oni, S., Diaku-Akinwumi, I. N., Adeniran, A., & Falase, B. (2018). Unprepared and misinformed parents of children with sickle cell disease: Time to rethink awareness campaigns. Cureus, 10(12), e3806. https://doi.org/10.7759/cureus.3806
- Attia, M., Kripalani, S., Darbari, I., & Nickel, R. S. (2020). Parents of children with sickle cell disease are interested in preimplantation genetic testing. The Journal of Pediatrics, 223, 178–182.e2. https://doi.org/10.1016/j.jpeds.2020.04.027
- Benson, J. M., & Therrell, B. L., Jr. (2010). History and current status of newborn screening for hemoglobinopathies. Seminars in Perinatology, 34(2), 134–144. https://doi.org/10.1053/j.semperi.2009.12.006
- Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., & Vichinsky, E. P. (2018). Sickle cell disease. Nature Reviews Disease Primers, 4(1), 18010. https://doi.org/10.1038/nrdp.2018.10
- Modell, B., & Darlison, M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization, 2008(6), 480–487. https://doi.org/10.2471/BLT.06.036673
- Ojodu, J., Hulihan, M. M., Pope, S. N., & Grant, A. M. (2014). Incidence of sickle cell trait–United States, 2010. MMWR. Morbidity and Mortality Weekly Report, 63(49), 1155–1158.
- Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. (2013). Recommendations for gamete and embryo donation: a committee opinion. Fertility and Sterility, 99(1), 47–62.e1. https://doi.org/10.1016/j.fertnstert.2012.09.037
- Sabath, D. E. (2017). Molecular diagnosis of thalassemias and hemoglobinopathies: An ACLPS critical review. American Journal of Clinical Pathology, 148(1), 6–15. https://doi.org/10.1093/ajcp/aqx047
- The American College of Obstetricians and Gynecologists. (2020). Committee opinion carrier screening for genetic testing. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/03/carrier-screening-for-genetic-conditions
- Traeger-Synodinos, J., & Harteveld, C. L. (2017). Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: Challenges and future perspectives. Expert Review of Molecular Diagnostics, 17(3), 281–291. https://doi.org/10.1080/14737159.2017.1285701
- Traeger-Synodinos, J., Harteveld, C. L., Old, J. M., Petrou, M., Galanello, R., Giordano, P., Angastioniotis, M., De la Salle, B., Henderson, S., & May, A. (2015). EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. European Journal of Human Genetics : EJHG, 23(4), 426–437. https://doi.org/10.1038/ejhg.2014.131
- Williams, T. N., & Weatherall, D. J. (2012). World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harbor Perspectives in Medicine, 2(9), a011692. https://doi.org/10.1101/cshperspect.a011692